Safety, Tolerability & Immunogenicity of the Recombinant Plague Vaccine rF1V

This study has been completed.

Study NCT00097396 Information provided by DynPort Vaccine Company LLC, A CSC Company

First Received: November 23, 2004 Last Updated: June 29, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	September 2006
Primary Completion Date:	July 2006 (Final data collection date for primary outcome measure)